6-(4-ethyl-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
|
Basic information |
| Metabolite name | 6-(4-ethyl-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid |
 | N/A |
 |
N/A |
 |
131831539 |
| Synonyms | NA |
| No. of studies | 1 |
|
Basic information |
| Metabolite name | 6-(4-ethyl-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid |
| N/A |
|
N/A |
|
131831539 |
| Synonyms | NA |
| No. of studies | 1 |
|
Relationship between 6-(4-ethyl-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid and depression (count: 1) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M949 | Type1 | ovariectomy group vs. control group | Serum | ICR mouse | Up |
| Study M949 | Type2 | ovariectomy + middle dose of Ginseng total saponins and Fuzi total alkaloids group vs. ovariectomy group | Serum | ICR mouse | Down |
| Study M949 | Type2 | ovariectomy + fluoxetine group vs. ovariectomy group | Serum | ICR mouse | Down |
| Study M949 | Type2 | ovariectomy + low dose of Ginseng total saponins and Fuzi total alkaloids group vs. ovariectomy group | Serum | ICR mouse | Down |
| Study M949 | Type2 | ovariectomy + high dose of Ginseng total saponins and Fuzi total alkaloids group vs. ovariectomy group | Serum | ICR mouse | Down |